Answers are grounded in this paper and cite their sources.
Randomized trial investigates kidney function outcomes in sickle cell mice following L-glutamine supplementation, suggesting metabolic activity without renal improvement.
Sickle cell disease (SCD) arises from a β-globin mutation that produces sickle hemoglobin (HbS), driving red cell sickling, vaso-occlusion, ischemia–reperfusion injury, and progressive organ damage. Oral L-glutamine was approved for SCD in 2017 based on trials suggesting antioxidant effects and fewer vaso-occlusive crises, but its mechanisms, renal safety, and efficacy remain unclear, and increased mortality has been reported in some patients with pre-existing organ dysfunction. However, the effects of dietary L-glutamine supplementation in SCD with preserved kidney function remain poorly understood. We investigated the impact of L-glutamine on basal renal function and the kidney proteome in humanized non-sickling (HbAA) and sickling (HbSS) Townes mice. HbSS and HbAA mice (12–16 weeks) were randomized for 10 weeks to a 15% fat control diet or the same diet supplemented with L-glutamine (200 g/3987 kcal). At necropsy, plasma creatinine, blood urea nitrogen (BUN), proteinuria, liver enzymes, oxidative stress markers, and plasma and urinary NGAL were assessed. Kidneys underwent quantitative proteomics with differential abundance (fold change ≥ 1.5, P ≤ 0.01, and Q ≤ 0.05) and pathway enrichment analyses (FDR < 0.05). Body weight was similar among groups except for a significant decrease in HbSS mice receiving L-glutamine. In HbSS mice, L-glutamine did not improve anemia, hemolysis, or splenomegaly. Plasma creatinine, BUN, proteinuria, and oxidative stress markers did not differ between control and L-glutamine-fed mice in either genotype. Plasma and urinary NGAL were increased in HbSS versus HbAA mice, but the L-glutamine diet did not ameliorate this increase. Proteomics identified 8,020 proteins. Under control diet conditions, HbSS versus HbAA kidneys showed 295 differentially expressed proteins enriched in the neutrophil extracellular trap formation pathway. In HbSS mice, L-glutamine versus the control diet altered 203 proteins, enriched in pathways involved in xenobiotic, retinol, and glutathione metabolism, whereas in HbAA mice, 216 proteins were altered, enriched in pathways involved in the metabolism of retinol, arachidonic acid, and folate transport. Under L-glutamine supplementation, HbSS versus HbAA kidneys exhibited 455 differentially expressed proteins enriched in the metabolism of retinol and porphyrin, the biosynthesis of steroids, unsaturated fatty acids, and primary bile acids, and pathways of antigen processing and presentation and fluid shear stress and atherosclerosis. Our findings suggest that in humanized sickle cell mice with relatively preserved kidney function, dietary L-glutamine did not alter conventional measures of renal function or injury, nor did it ameliorate anemia, hemolysis, or splenomegaly, despite being associated with weight loss in HbSS animals. However, L-glutamine induced extensive, genotype-dependent remodeling of the renal proteome. Therefore, dietary L-glutamine supplementation appears functionally neutral but metabolically active in the SCD kidney, warranting further mechanistic and longitudinal investigation. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
No takes yet. Share an insight, caveat, or question.
Arishe et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: